                         SEQUENCE LISTING

<110>  Bar ILAN University
 
<120>  New Peptide Vaccines and Uses Thereof

<130>  195192272

<150>  63/034,416
<151>  2020-06-04

<160>  45    

<170>  PatentIn version 3.5

<210>  1
<211>  17
<212>  PRT
<213>  SARS-CoV-2

<400>  1

Pro Lys Glu Ile Thr Val Ala Thr Ser Arg Thr Leu Ser Tyr Tyr Lys 
1               5                   10                  15      


Leu 
    


<210>  2
<211>  17
<212>  PRT
<213>  SARS-CoV-2

<400>  2

Gln Phe Ala Pro Ser Ala Ser Ala Phe Phe Gly Met Ser Arg Ile Gly 
1               5                   10                  15      


Met 
    


<210>  3
<211>  17
<212>  PRT
<213>  SARS-CoV-2

<400>  3

Phe Phe Gly Met Ser Arg Ile Gly Met Glu Val Thr Pro Ser Gly Thr 
1               5                   10                  15      


Trp 
    


<210>  4
<211>  17
<212>  PRT
<213>  SARS-CoV-2

<400>  4

Phe Ile Glu Asp Leu Leu Phe Asn Lys Val Thr Leu Ala Asp Ala Gly 
1               5                   10                  15      


Phe 
    


<210>  5
<211>  17
<212>  PRT
<213>  SARS-CoV-2

<400>  5

Gly Ala Ala Leu Gln Ile Pro Phe Ala Met Gln Met Ala Tyr Arg Phe 
1               5                   10                  15      


Asn 
    


<210>  6
<211>  17
<212>  PRT
<213>  SARS-CoV-2

<400>  6

Pro Phe Ala Met Gln Met Ala Tyr Arg Phe Asn Gly Ile Gly Val Thr 
1               5                   10                  15      


Gln 
    


<210>  7
<211>  28
<212>  PRT
<213>  SARS-CoV-2

<400>  7

Glu Ile Asp Arg Leu Asn Glu Val Ala Lys Asn Leu Asn Glu Ser Leu 
1               5                   10                  15      


Ile Asp Leu Gln Glu Leu Gly Lys Tyr Glu Gln Tyr 
            20                  25              


<210>  8
<211>  10
<212>  PRT
<213>  SARS-CoV-2

<400>  8

Thr Leu Ala Cys Phe Val Leu Ala Ala Val 
1               5                   10  


<210>  9
<211>  18
<212>  PRT
<213>  SARS-CoV-2

<400>  9

Gly Arg Cys Asp Ile Lys Asp Leu Pro Lys Glu Ile Thr Val Ala Thr 
1               5                   10                  15      


Ser Arg 
        


<210>  10
<211>  16
<212>  PRT
<213>  SARS-CoV-2

<400>  10

Thr Ser Arg Thr Leu Ser Tyr Tyr Lys Leu Gly Ala Ser Gln Arg Val 
1               5                   10                  15      


<210>  11
<211>  18
<212>  PRT
<213>  SARS-CoV-2

<400>  11

Gln Gln Gln Gly Gln Thr Val Thr Lys Lys Ser Ala Ala Glu Ala Ser 
1               5                   10                  15      


Lys Lys 
        


<210>  12
<211>  17
<212>  PRT
<213>  SARS-CoV-2

<400>  12

Ile Arg Gln Gly Thr Asp Tyr Lys His Trp Pro Gln Ile Ala Gln Phe 
1               5                   10                  15      


Ala 
    


<210>  13
<211>  16
<212>  PRT
<213>  SARS-CoV-2

<400>  13

Ser Arg Gly Gly Ser Gln Ala Ser Ser Arg Ser Ser Ser Arg Ser Arg 
1               5                   10                  15      


<210>  14
<211>  17
<212>  PRT
<213>  SARS-CoV-2

<400>  14

Lys Lys Ser Ala Ala Glu Ala Ser Lys Lys Pro Arg Gln Lys Arg Thr 
1               5                   10                  15      


Ala 
    


<210>  15
<211>  19
<212>  PRT
<213>  SARS-CoV-2

<400>  15

Tyr Asn Val Thr Gln Ala Phe Gly Arg Arg Gly Pro Glu Gln Thr Gln 
1               5                   10                  15      


Gly Asn Phe 
            


<210>  16
<211>  17
<212>  PRT
<213>  SARS-CoV-2

<400>  16

Ala Ala Thr Lys Met Ser Glu Cys Val Leu Gly Gln Ser Lys Arg Val 
1               5                   10                  15      


Asp 
    


<210>  17
<211>  9
<212>  PRT
<213>  SARS-CoV-2

<400>  17

Val Val Phe Leu His Val Thr Tyr Val 
1               5                   


<210>  18
<211>  17
<212>  PRT
<213>  SARS-CoV-2

<400>  18

Lys Asn His Thr Ser Pro Asp Val Asp Leu Gly Asp Ile Ser Gly Ile 
1               5                   10                  15      


Asn 
    


<210>  19
<211>  17
<212>  PRT
<213>  SARS-CoV-2

<400>  19

Arg Ala Ser Ala Asn Leu Ala Ala Thr Lys Met Ser Glu Cys Val Leu 
1               5                   10                  15      


Gly 
    


<210>  20
<211>  17
<212>  PRT
<213>  SARS-CoV-2

<400>  20

Asp Leu Gly Asp Ile Ser Gly Ile Asn Ala Ser Val Val Asn Ile Gln 
1               5                   10                  15      


Lys 
    


<210>  21
<211>  20
<212>  PRT
<213>  SARS-CoV-2

<400>  21

Cys Lys Phe Asp Glu Asp Asp Ser Glu Pro Val Leu Lys Gly Val Lys 
1               5                   10                  15      


Leu His Tyr Thr 
            20  


<210>  22
<211>  17
<212>  PRT
<213>  SARS-CoV-2

<400>  22

Val Arg Phe Pro Asn Ile Thr Asn Leu Cys Pro Phe Gly Glu Val Phe 
1               5                   10                  15      


Asn 
    


<210>  23
<211>  18
<212>  PRT
<213>  SARS-CoV-2

<400>  23

Asp Ile Pro Ile Gly Ala Gly Ile Cys Ala Ser Tyr His Thr Val Ser 
1               5                   10                  15      


Leu Leu 
        


<210>  24
<211>  17
<212>  PRT
<213>  SARS-CoV-2

<400>  24

Met Ala Tyr Arg Phe Asn Gly Ile Gly Val Thr Gln Asn Val Leu Tyr 
1               5                   10                  15      


Glu 
    


<210>  25
<211>  16
<212>  PRT
<213>  SARS-CoV-2

<400>  25

Tyr Lys Thr Phe Pro Pro Thr Glu Pro Lys Lys Asp Lys Lys Lys Lys 
1               5                   10                  15      


<210>  26
<211>  51
<212>  DNA
<213>  SARS-CoV-2

<400>  26
cctaaagaaa tcactgttgc tacatcacga acgctttctt attacaaatt g                51


<210>  27
<211>  51
<212>  DNA
<213>  SARS-CoV-2

<400>  27
caatttgccc ccagcgcttc agcgttcttc ggaatgtcgc gcattggcat g                51


<210>  28
<211>  51
<212>  DNA
<213>  SARS-CoV-2

<400>  28
ttcttcggaa tgtcgcgcat tggcatggaa gtcacacctt cgggaacgtg g                51


<210>  29
<211>  51
<212>  DNA
<213>  SARS-CoV-2

<400>  29
tttattgaag atctactttt caacaaagtg acacttgcag atgctggctt c                51


<210>  30
<211>  51
<212>  DNA
<213>  SARS-CoV-2

<400>  30
ggtgctgcat tacaaatacc atttgctatg caaatggctt ataggtttaa t                51


<210>  31
<211>  51
<212>  DNA
<213>  SARS-CoV-2

<400>  31
ccatttgcta tgcaaatggc ttataggttt aatggtattg gagttacaca g                51


<210>  32
<211>  84
<212>  DNA
<213>  SARS-CoV-2

<400>  32
gaaattgacc gcctcaatga ggttgccaag aatttaaatg aatctctcat cgatctccaa       60

gaacttggaa agtatgagca gtat                                              84


<210>  33
<211>  34
<212>  PRT
<213>  SARS-CoV-2

<400>  33

Met Ala Tyr Arg Phe Asn Gly Ile Gly Val Thr Gln Asn Val Leu Tyr 
1               5                   10                  15      


Glu Pro Lys Glu Ile Thr Val Ala Thr Ser Arg Thr Leu Ser Tyr Tyr 
            20                  25                  30          


Lys Leu 
        


<210>  34
<211>  34
<212>  PRT
<213>  SARS-CoV-2

<400>  34

Pro Lys Glu Ile Thr Val Ala Thr Ser Arg Thr Leu Ser Tyr Tyr Lys 
1               5                   10                  15      


Leu Met Ala Tyr Arg Phe Asn Gly Ile Gly Val Thr Gln Asn Val Leu 
            20                  25                  30          


Tyr Glu 
        


<210>  35
<211>  36
<212>  PRT
<213>  SARS-CoV-2

<400>  35

Pro Phe Ala Met Gln Met Ala Tyr Arg Phe Asn Gly Ile Gly Val Thr 
1               5                   10                  15      


Gln Thr Leu Ala Cys Phe Val Leu Ala Ala Val Val Val Phe Leu His 
            20                  25                  30          


Val Thr Tyr Val 
        35      


<210>  36
<211>  36
<212>  PRT
<213>  SARS-CoV-2

<400>  36

Val Val Phe Leu His Val Thr Tyr Val Thr Leu Ala Cys Phe Val Leu 
1               5                   10                  15      


Ala Ala Val Asp Leu Gly Asp Ile Ser Gly Ile Asn Ala Ser Val Val 
            20                  25                  30          


Asn Ile Gln Lys 
        35      


<210>  37
<211>  53
<212>  PRT
<213>  SARS-CoV-2

<400>  37

Thr Leu Ala Cys Phe Val Leu Ala Ala Val Lys Lys Ser Ala Ala Glu 
1               5                   10                  15      


Ala Ser Lys Lys Pro Arg Gln Lys Arg Thr Ala Val Val Phe Leu His 
            20                  25                  30          


Val Thr Tyr Val Ala Ala Thr Lys Met Ser Glu Cys Val Leu Gly Gln 
        35                  40                  45              


Ser Lys Arg Val Asp 
    50              


<210>  38
<211>  43
<212>  PRT
<213>  SARS-CoV-2

<400>  38

Pro Phe Ala Met Gln Met Ala Tyr Arg Phe Asn Gly Ile Gly Val Thr 
1               5                   10                  15      


Gln Val Val Phe Leu His Val Thr Tyr Val Met Ala Tyr Arg Phe Asn 
            20                  25                  30          


Gly Ile Gly Val Thr Gln Asn Val Leu Tyr Glu 
        35                  40              


<210>  39
<211>  35
<212>  PRT
<213>  SARS-CoV-2

<400>  39

Val Val Phe Leu His Val Thr Tyr Val Tyr Lys Thr Phe Pro Pro Thr 
1               5                   10                  15      


Glu Pro Lys Lys Asp Lys Lys Lys Lys Thr Leu Ala Cys Phe Val Leu 
            20                  25                  30          


Ala Ala Val 
        35  


<210>  40
<211>  33
<212>  PRT
<213>  SARS-CoV-2

<400>  40

Tyr Lys Thr Phe Pro Pro Thr Glu Pro Lys Lys Asp Lys Lys Lys Lys 
1               5                   10                  15      


Pro Phe Ala Met Gln Met Ala Tyr Arg Phe Asn Gly Ile Gly Val Thr 
            20                  25                  30          


Gln 
    


<210>  41
<211>  26
<212>  PRT
<213>  SARS-CoV-2

<400>  41

Gly Ala Ala Leu Gln Ile Pro Phe Ala Met Gln Met Ala Tyr Arg Phe 
1               5                   10                  15      


Asn Val Val Phe Leu His Val Thr Tyr Val 
            20                  25      


<210>  42
<211>  33
<212>  PRT
<213>  SARS-CoV-2

<400>  42

Pro Phe Ala Met Gln Met Ala Tyr Arg Phe Asn Gly Ile Gly Val Thr 
1               5                   10                  15      


Gln Tyr Lys Thr Phe Pro Pro Thr Glu Pro Lys Lys Asp Lys Lys Lys 
            20                  25                  30          


Lys 
    


<210>  43
<211>  55
<212>  PRT
<213>  SARS-CoV-2

<400>  43

Asp Leu Gly Asp Ile Ser Gly Ile Asn Ala Ser Val Val Asn Ile Gln 
1               5                   10                  15      


Lys Glu Ile Asp Arg Leu Asn Glu Val Ala Lys Asn Leu Asn Glu Ser 
            20                  25                  30          


Leu Ile Asp Leu Gln Glu Leu Gly Lys Tyr Glu Gln Tyr Ile Lys Trp 
        35                  40                  45              


Pro Trp Tyr Ile Trp Leu Gly 
    50                  55  


<210>  44
<211>  60
<212>  PRT
<213>  SARS-CoV-2

<400>  44

Gln Gln Gln Gly Gln Thr Val Thr Lys Lys Ser Ala Ala Glu Ala Ser 
1               5                   10                  15      


Lys Lys Glu Ile Asp Arg Leu Asn Glu Val Ala Lys Asn Leu Asn Glu 
            20                  25                  30          


Ser Leu Ile Asp Leu Gln Glu Leu Gly Lys Tyr Glu Gln Tyr Ile Lys 
        35                  40                  45              


Asp Leu Pro Lys Glu Ile Thr Val Ala Thr Ser Arg 
    50                  55                  60  


<210>  45
<211>  58
<212>  PRT
<213>  SARS-CoV-2

<400>  45

Tyr Lys Thr Phe Pro Pro Thr Glu Pro Lys Lys Asp Lys Lys Lys Lys 
1               5                   10                  15      


Glu Ile Asp Arg Leu Asn Glu Val Ala Lys Asn Leu Asn Glu Ser Leu 
            20                  25                  30          


Ile Asp Leu Gln Glu Leu Gly Lys Tyr Glu Gln Tyr Ile Lys Asp Leu 
        35                  40                  45              


Pro Lys Glu Ile Thr Val Ala Thr Ser Arg 
    50                  55              


